Amorce

Myths vs evidence

Ten things people say about ADHD, and what the research actually supports.

  • “ADHD isn’t real — it was invented to sell medication.”

    False

    ADHD is one of the most studied conditions in psychiatry, with consistent findings across countries and decades.

    Faraone et al. 2021
    1. Consensus statement Faraone SV, Banaschewski T, Coghill D, et al. (80 authors) (2021). The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789–818. Open source ↗Only included findings from meta-analyses or studies with more than 2,000 participants.
  • “ADHD is caused by bad parenting.”

    False

    Genetic influences are strong (heritability around 74%). Parenting can affect how things go, but it doesn’t cause ADHD.

    Faraone et al. 2019
    1. Narrative review Faraone SV, Larsson H (2019). Genetics of attention deficit hyperactivity disorder. Molecular Psychiatry, 24, 562–575. Open source ↗Mean heritability ≈ 74% across twin studies.
  • “Everyone is a little bit ADHD.”

    Misleading

    ADHD traits exist on a continuum, but a diagnosis requires persistent, impairing symptoms since childhood. Having some traits isn’t the same thing.

    Faraone et al. 2021 +1
    1. Consensus statement Faraone SV, Banaschewski T, Coghill D, et al. (80 authors) (2021). The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789–818. Open source ↗Only included findings from meta-analyses or studies with more than 2,000 participants.
    2. Clinical guideline American Psychiatric Association (2022). Diagnostic and Statistical Manual of Mental Disorders, 5th edition, text revision (DSM-5-TR). APA Publishing. Open source ↗Adults (17+): at least 5 symptoms in a domain; several before age 12; in 2+ settings; clear impairment.
  • “You grow out of ADHD.”

    It fluctuates

    Symptoms often ease with age, but lasting remission is rare: in a cohort followed for 16 years, only about 9% stayed in remission, and most people alternated between periods of remission and recurrence. About 2.6% of adults worldwide have persistent ADHD.

    Sibley et al. 2022 +2
    1. Cohort / register study Sibley MH, Arnold LE, Swanson JM, et al. (2022). Variable patterns of remission from ADHD in the Multimodal Treatment Study of ADHD. American Journal of Psychiatry, 179(2), 142–151. Open source ↗558 children followed 16 years; sustained remission was rare, fluctuating courses common.
    2. Meta-analysis Song P, et al. (2021). The prevalence of adult attention-deficit hyperactivity disorder: a global systematic review and meta-analysis. Journal of Global Health, 11, 04009. Open source ↗Persistent adult ADHD 2.58%; symptomatic adult ADHD 6.76%.
    3. Narrative review Franke B, Michelini G, Asherson P, et al. (2018). Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. European Neuropsychopharmacology, 28(10), 1059–1088. Open source ↗
  • “ADHD is much more common in boys.”

    Misleading

    Boys are diagnosed far more often in childhood (~4:1), but the gap shrinks a lot in adults (~1.9:1 in one large study). Girls are more often missed.

    Martin et al. 2024
    1. Cohort / register study Martin J, et al. (2024). Sex differences in attention-deficit hyperactivity disorder diagnosis and clinical care: a national study of population healthcare records in Wales. Journal of Child Psychology and Psychiatry, 65(12), 1648–1658. Open source ↗16,458 people diagnosed with ADHD.
  • “If you can focus on video games, you can’t have ADHD.”

    False

    ADHD affects the regulation of attention. Highly engaging activities often hold attention fine; the difficulty shows with less rewarding tasks.

    Sonuga-Barke 2003 +1
    1. Theory paper Sonuga-Barke EJS (2003). The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neuroscience & Biobehavioral Reviews, 27(7), 593–604. Open source ↗Proposes an executive pathway and a motivational (delay aversion) pathway.
    2. Meta-analysis Jackson JNS, MacKillop J (2016). Attention-deficit/hyperactivity disorder and monetary delay discounting: a meta-analysis of case-control studies. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 1(4), 316–325. Open source ↗Rewards that come later are valued less, on average.
  • “ADHD medication works long-term for everyone.”

    Unknown

    Medication reduces symptoms in the short term for many people. There are no decades-long randomised trials. Large register studies suggest lower mortality with treatment (about −19% over two years) and a small rise in cardiovascular risk with years of use (about +4% per year) — observational findings, where other factors may play a part. Who benefits most is still unclear.

    Cortese et al. 2018 +3
    1. Meta-analysis Cortese S, Adamo N, Del Giovane C, et al. (2018). Comparative efficacy and tolerability of medications for ADHD in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet Psychiatry, 5(9), 727–738. Open source ↗133 double-blind randomised trials; short-term outcomes (about 12 weeks).
    2. Meta-analysis Ostinelli EG, et al. (senior author: Cortese S) (2025). Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis. The Lancet Psychiatry. Open source ↗Adults only. Short-term symptom benefits for stimulants and atomoxetine; little evidence on quality of life or long-term outcomes.
    3. Cohort / register study Li L, Zhu N, Zhang L, et al. (2024). ADHD pharmacotherapy and mortality in individuals with ADHD. JAMA, 331(10), 850–860. Open source ↗Swedish register, ~149,000 people; observational — lower all-cause mortality over two years with treatment, mainly from unnatural causes.
    4. Cohort / register study Zhang L, Li L, Andell P, et al. (2024). Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases. JAMA Psychiatry, 81(2), 178–187. Open source ↗Swedish case-control study; about +4 % cardiovascular risk per year of use, mostly hypertension and arterial disease.
  • “People with ADHD lack object permanence.”

    False

    Object permanence is a developmental milestone reached in infancy. “Out of sight, out of mind” in ADHD is better described as a working-memory and prospective-memory difficulty.

    Yeung et al. 2022 +1
    1. Cross-sectional study Yeung A, Ng E, Abi-Jaoude E (2022). TikTok and attention-deficit/hyperactivity disorder: a cross-sectional study of social media content quality. Canadian Journal of Psychiatry. Open source ↗52 of the 100 most-viewed #ADHD videos were rated misleading.
    2. Meta-analysis Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF (2005). Validity of the executive function theory of ADHD: a meta-analytic review. Biological Psychiatry, 57(11), 1336–1346. Open source ↗83 studies. Moderate group differences; fewer than half of people with ADHD show impairment on any given executive task.
  • “ADHD symptoms get worse before your period.”

    Possibly, for some

    Small studies and many personal reports suggest this. We don’t yet know how common it is or why.

    Osianlis et al. 2025 +1
    1. Systematic review Osianlis E, Thomas EHX, Jenkins LM, Gurvich C (2025). ADHD and sex hormones in females: a systematic review. Journal of Attention Disorders. Open source ↗11 studies; only 6 with a formal ADHD diagnosis; none empirically studying menopause.
    2. Systematic review Kennedy G, Baran-Goldwax M, Lippé S (2026). Menstrual health and attention-deficit/hyperactivity disorder (ADHD) symptoms: a scoping review. Women’s Health. Open source ↗20 studies (2014–2025); most under 200 participants.
  • “Body doubling is a proven ADHD strategy.”

    Untested

    Many people find it helpful. Rigorous studies barely exist yet.

    Body-doubling EEG study 2025
    1. Cross-sectional study See original article (2025). Reading between the lines: exploring body doubling in ADHD using EEG. Proceedings of ACM SIGACCESS ASSETS 2025. Open source ↗Small study; no significant difference versus working alone.